Literature DB >> 31288719

A Review on Anticancer Potentials of Benzothiazole Derivatives.

Nandini Pathak1, Ekta Rathi2, Nitesh Kumar1, Suvarna G Kini2, C Mallikarjuna Rao1.   

Abstract

Benzothiazole is an organic compound bearing a heterocyclic nucleus (thiazole) which imparts a broad spectrum of biological activities to it. The significant and potent activity of benzothiazole moiety influenced distinctively by nature and position of substitutions. This review summarizes the effect of various substituents in recent trends and approaches to design and develop novel benzothiazole derivatives for anticancer potential in different cell lines by interpreting the Structure- Activity Relationship (SAR) and mechanism of action of a wide range of derivatives. The list of derivatives is categorized into different groups and reviewed for their anticancer activity. The structure-activity relationship for the various derivatives revealed an excellent understanding of benzothiazole moiety in the field of cancer therapy against different cancer cell line. Data obtained from the various articles showed the potential effect of benzothiazole moiety and its derivatives to produce the peculiar and significant lead compound. The important anticancer mechanisms found are tyrosine kinase inhibition, topoisomerase inhibition and induction of apoptosis by Reactive Oxygen Species (ROS) activation. Therefore, the design and development of novel benzothiazole have broad scope in cancer chemotherapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Benzothiazole; Topoisomerase inhibition; anticancer; apoptosis; cell line mechanism of action; structure-activity relationship; tyrosine kinase inhibition.

Year:  2020        PMID: 31288719     DOI: 10.2174/1389557519666190617153213

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  7 in total

1.  Evaluation of anti-glioma effects of benzothiazoles as efficient apoptosis inducers and DNA cleaving agents.

Authors:  Belgin Sever; Halilibrahim Ciftci
Journal:  Mol Cell Biochem       Date:  2022-10-11       Impact factor: 3.842

Review 2.  Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer.

Authors:  Nitin Tandon; Vijay Luxami; Divya Kant; Runjhun Tandon; Kamaldeep Paul
Journal:  RSC Adv       Date:  2021-07-20       Impact factor: 4.036

Review 3.  Synthetic Approaches to Biologically Active C-2-Substituted Benzothiazoles.

Authors:  Bagrat A Shainyan; Larisa V Zhilitskaya; Nina O Yarosh
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.927

4.  Preparation and application of FNAOSiPPEA/Cu(II) as a novel magnetite almondshell based Lewis acid-Bronsted base nano-catalyst for the synthesis of pyrimidobenzothiazoles.

Authors:  Dina Mallah; Bi Bi Fatemeh Mirjalili
Journal:  BMC Chem       Date:  2022-06-11

5.  In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.

Authors:  Belgin Sever; Mehlika Dilek Altıntop; Ahmet Özdemir; Gülşen Akalın Çiftçi; Doha E Ellakwa; Hiroshi Tateishi; Mohamed O Radwan; Mahmoud A A Ibrahim; Masami Otsuka; Mikako Fujita; Halil I Ciftci; Taha F S Ali
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

6.  Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer.

Authors:  Nadeen M El-Ghobashy; Selwan M El-Sayed; Ihsan A Shehata; Mahmoud B El-Ashmawy
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

Review 7.  A Compendium of the Most Promising Synthesized Organic Compounds against Several Fusarium oxysporum Species: Synthesis, Antifungal Activity, and Perspectives.

Authors:  Paola Borrego-Muñoz; Felipe Ospina; Diego Quiroga
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.